Iatrogenic disease impact on emergency consultations
DrugDetermination of the proportion of emergency consultations linked to iatrogenic diseases
NCT Number: NCT03960398
French population grows older year after year: 24.3% people were over 60 years old in 2006 against 20.6% in 2000 and the expected number might be over 33% in 2050.
The elderly suffer from lots of illnesses, so they usually take lots of drugs. Therefore, this drug use is most likely to have adverse drug reactions.
Finally, according to Health Ministry, the number of emergency department consultations doubled from 1996 to 2016.
Consequently, it is interesting to study the impact of drug iatrogenic effects on emergency consultations.
It would help to prevent these adverse drug reactions as we prescribe those drugs : First, do not harm.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Centre Hospitalier Intercommunal de Toulon - La Seyne sur Mer, La Seyne-sur-Mer, Var, France
This will be a retrospective study.
The number of patients will be defined by the number of visits during a random draw of 10 emergency department consultation days between 21st June 2018 and 22nd September 2018 in Toulon - La Seyne sur Mer public hospital.
There are between 100 and 300 emergency department consultations per day in this hospital so the estimated number of patients will be between 1000 and 3000.
Every patient who came to hospital for a consultation in emergency department during this period of time will be included in the study except those who expressed their opposition to their data collection and treatment.
Each patient will be anonymized with a code defined as follows : N(ame) L(ast name) 001 (chronological inclusion number)
Information of the patients involved in adverse drug reactions will be extracted and a description of this patient sample will be made.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Determination of the proportion of emergency consultations linked to iatrogenic diseases
Time frame: 10 days (chosen at random between 21st June and 22nd September 2018)
We will study each case and determine whether the consultation in the emergency department is due to adverse drug reaction or not.Number of patients having an emergency department consultation because of an adverse drug reaction divided by the total number of patients having an emergency department consultation during the same period of time.
Time frame: 10 days
Average and standard deviation of patient age among the patients consulting in emergency department because of an adverse drug reaction.
Time frame: 10 days
Number of male and female patients consulting in emergency department because of an adverse drug reaction divided by the total number of patients consulting in emergency department because of an adverse drug reaction.
Time frame: 1 day
Number of treatments patients were taking when they arrived in emergency department for a consultation because of an adverse drug reaction
Time frame: 10 days
For each drug leading, during the 10 chosen days, to a consultation because of an adverse reaction, number of times when this drug was at the origin of a consultation
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Other
Incidence of Iatrogenic Diseases on Toulon-La Seyne Sur Mer Hospital Emergency Consultations During Summer 2018
Acronym: EIU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07148661
Disease Attributes, Iatrogenic Disease
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05639231
Asthenia, Atrophy
Baden, Canton of Aargau, Switzerland
View Trial DetailsNCT05017948
Behavior, Disease Attributes
Somerville, New Jersey, United States
View Trial DetailsNCT05336656
ARDS, COVID-19
Wilkes-Barre, Pennsylvania, United States
View Trial Details